Form 8-Kאופקו חתמה על הסכם לפיו תעניק לחברת CAMP4רשיון לפיתוח יצור ומסחור תרפות בטכנולגייתAntagoNAT
false
אופקו הלת', אינק
2
380
OPKO HEALTH, INC
Corporation no:
2279206
13156
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
12/07/2021
www.isa.gov.il
www.tase.co.il
Reference:
2021-02-052024
Time of broadcast:
21:52
21:52
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Form 8-K אופקו חתמה על הסכם לפיו תעניק לחברת CAMP4 רשיון לפיתוח יצור ומסחור תרפות בטכנולגיית AntagoNAT
20210712Form8K_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NASDAQ GSM
Date of revision of form structure:
15/06/2021
Address:
Ashlegan
16
,
Kiryat Gat
8211804
Israel
,
Tel:
08-9300051
,
Fax:
08-9543101
E-mail address:
gfaibish@opko.com
Company site:
Www.Opko.Com
Previous names of reporting entity:
Name of the Signatory:
Faibish Gabriel
Position of Signatory in the reporting corporation:
General Counsel
Name of Employer Company:
Address:
Ashlegan
16
,
Kiryat Gat
8211804
Telephone:
08-9300051
Facsimile:
08-9543101
E-mail:
gfaibish@opko.com
1